Skip to content

Early Diagnosis of Intracranial Infection After Craniotomy

Role of Postoperative Fever, Serum Procalcitonin, C-reactive Protein and White Blood Cell Count in the Diagnosis of Intracranial Infection After Craniotomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04215094
Enrollment
500
Registered
2020-01-09
Start date
2020-01-12
Completion date
2021-08-01
Last updated
2020-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial; Infection, Psychosis, Acute or Subacute

Keywords

Procalcitonin, C-reactive protein, white blood cell count, intracranial infection

Brief summary

Intracranial infection are serious complications postoperatively in neurosurgical patients. Early identification of these complications is essential to minimize the mortality and moribidy. The aim of this study is observe the postoperative dynamic changes of body temperature (BT), procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy of intracranial infection.

Detailed description

Intracranial infection is a serious complications after neurosurgical operation. Early identification of intracranial infection is important so that, first, optimal treatment is initiated which may improves outcome, second, inappropriate antibiotic treatment and subsequent resistance are prevented, and third, it will promote shorter hospitalization and less cost. In several previous studies, the values of procalcitonin (PCT) and C-reactive protein (CRP) in predicting intracranial infection have been evaluated in neurosurgical patients. However, due to the limited number of studies, the results are not convincing enough and more investigations seems warranted to clarify their dynamic changes in neurosurgical patients without intracranial infection and their role in confirming the suspicion of intracranial infection or excluding intracranial infection from the differential diagnosis. The aim of the investigator's study is to observe the postoperative dynamic changes of BT, PCT, CRP, and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy for rational decisions about antibiotic treatment.

Interventions

DIAGNOSTIC_TESTpostoperative fever, serum procalcitonin, C-reactive protein and white blood cell coun

All patients in Intracranial Infection group were cured with antibiotic treatment

Sponsors

Pan Jun
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 68 Years
Healthy volunteers
Yes

Inclusion criteria

1. craniotomy of brain tumor; 2. no clinical manifestations of infection before operation; 3. no other infection such as respiratory tract infection, urinary tract infection and deep vein catheter infection before the definite diagnosis of intracranial infection ; 4. the patients had informed consent to enter the study.

Exclusion criteria

1. blood system diseases,respiratory tract infection, urinary tract infection and deep vein catheter infection; 2. malignant tumors with neuroendocrine characteristicsr; 3. aspiration, pancreatitis, etc.

Design outcomes

Primary

MeasureTime frameDescription
the diagnosis of intracranial infection after craniotomyup to 100 weeksIntracranial infection are serious complications postoperatively in neurosurgical patients. Early identification of these complications is essential to minimize the mortality and moribidy. The aim of this study is observe the postoperative dynamic changes of body temperature (BT), procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy of intracranial infection

Countries

China

Contacts

Primary ContactXi'an Zhang, doctor
48831443@qq.com+86-020-61641815
Backup ContactJunxiang Peng, doctor
pjxlaozong@126.com+86-020-616418006

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026